NCR Graphs - All Cancers

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	314,437,416 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	52,597,003 L.L
A10AD04	HUMALOG MIX 25 KWIKPEN	BioTech	Insulin lispro solution - 25%, Insulin lispro protamine suspension - 75%	100IU/ml	Injectable suspension	3,950,897 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	179,063,666 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	164,970,376 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	91,457,321 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	494,909,963 L.L
L04AB02	REMSIMA SC	BioTech	Infliximab - 120mg/ml	120mg/ml	Injectable solution	52,597,003 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution + solvent	34,948,930 L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
A10AD06	RYZODEG	BioTech	Insulin degludec - 70%, Insulin aspart - 30%	100IU/ml	Injectable solution	7,058,661 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L04AB04	ABRILADA	BioTech	Adalimumab - 40mg	40mg	Injectable solution	40,259,574 L.L
A10AE01	HUMULIN N U-100	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	701,486 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L04AB04	ADALIREL	BioTech	Adalimumab - 40mg	40mg	Injectable solution	15,102,158 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,046,707 L.L
L04AB04	CINNORA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	14,817,734 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
L01FD01	MABTIN 440	BioTech	Trastuzumab (r-DNA origin) - 440mg	440mg	Injectable powder for solution	70,042,700 L.L

رسومات بيانية لسجل الوطني للسرطان - نسب الحدوث حسب السنوات